Insilico Medicine pulls back the curtain on developmental timelines, highlighting a ~13 month average timeline to reach developmental candidate (DC) nomination across 22 programs. Insilico’s QPCTL ...

Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...

AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...

The growth of the cell culture media market is driven by rising demand for biopharmaceuticals, vaccines, and cell-based therapies, fueled by advancements in biotechnology and life sciences research.

Hyderabad: BioAsia, Asia's largest annual global biotechnology and life sciences forum, announced that the prestigious Genome ...

The global cell counting market, valued at US$10.82 billion in 2023, is forecasted to grow at a robust CAGR of 7.7%, reaching ...

Anthos Therapeutics was set up by Blackstone Life Sciences after it licensed abelacimab drug from Novartis in 2019 ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

BioAstra, a pioneering force in space medicine and biotechnology, is set to revolutionize human health with the launch of Twin Astra-a first-of-its-kind deep-space research initiative poised to ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

Biovet, a subsidiary of the Bharat Biotech Group, has received approval from the CDSCO for its innovative LSD vaccine, ...